HTG Molecular Diagnostics, Inc. Made Headway
Tue, Jun 28, 2022 at 08:33 PM
HTG Molecular Diagnostics, Inc. (HTGM:NASDAQ) shot up at $0.84, a gain of 52.2%. On Tue, Jun 28, 2022, HTGM:NASDAQ hit a New 2-Week High of $0.84. The stock got featured on our News Catalysts scanner on Wed, Jun 08, 2022 at 04:19 PM in the 'BIOTECH' category. From Tue, Jun 14, 2022, the stock recorded 55.56% Up Days and 40.00% Green Days
The stock spiked on Tue, Jun 28, 2022 at $1.11 with a volume of 33M+.
About HTG Molecular Diagnostics, Inc. (HTGM:NASDAQ)
HTG Molecular Diagnostics Inc is a commercial stage company. It develops & markets a novel technology platform to facilitate the routine use of complex molecular profiling with its focus on clinical applications.
Top 10 Gainers:
- Agile Therapeutics, Inc. (AGRX:NASDAQ), 89.76%
- Endo International plc (ENDP:NASDAQ), 85.33%
- HTG Molecular Diagnostics, Inc. (HTGM:NASDAQ), 52.17%
- Tuniu Corporation (TOUR:NASDAQ), 46.01%
- Agrico Acquisition Corp. (RICO:NASDAQ), 43.66%
- Kezar Life Sciences, Inc. (KZR:NASDAQ), 43.43%
- InflaRx N.V. (IFRX:NASDAQ), 40.74%
- EzFill Holdings Inc. (EZFL:NASDAQ), 35.59%
- Graybug Vision Inc. (GRAY:NASDAQ), 35.38%
- Motorsport Games Inc. (MSGM:NASDAQ), 29.63%